The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.

William Blair has hand-picked its top five stock recommendations for 2026, selections that include three clinical-stage ...

Sanofi has agreed to acquire vaccine maker Dynavax Technologies in an all-cash deal worth $2.2 billion in total equity value.

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

Abivax (ABVX) stock leads biotech M&A prospects for 2026 while Madrigal Pharmaceuticals (MDGL) trails, according to a survey ...

In this article, we will be taking a look at the 10 Best Biotech Stocks to Buy Under $10. The head biotech analyst at Goldman Sachs, Salveen Richter, appeared on CNBC’s “Squawk Box” on July 25 to ...

CRISPR Therapeutics (NASDAQ: CRSP) soared a few years ago, climbing more than 200% from the start of 2020 through early 2021, ...

Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro ...

This stock is a great choice for cautious and aggressive investors.

An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...